Analysis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: Methodology and assay validation

Journal of Pharmaceutical and Biomedical Analysis

Volumn 36, Issue 5, 2005, Pages 1099-1105

  McCarron, Paul A ^a   Donnelly, Ryan F ^a   Woolfson, A David ^a   Andrews, Gavin P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

5 Aminolevulinic acid; Assay validation; Degradation; Drug delivery; Photodynamic therapy; Pyrazine 2,5 dipropionic acid

Indexed keywords

2,5 DIPROPIONIC ACID; AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PORPHIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER IRRIGATION; DIAGNOSTIC PROCEDURE; DRUG DELIVERY SYSTEM; DRUG SAFETY; ELUTION; ENVIRONMENTAL TEMPERATURE; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; URINALYSIS; UROLOGY; VALIDATION PROCESS;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; DRUG DELIVERY SYSTEMS; PROPIONIC ACIDS; PYRAZINES; URINARY BLADDER;

EID: 11144269674     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.09.004     Document Type: Article

References (31)

1. M.J. Gannon, and S.B. Brown Br. J. Obstet. Gynaecol. 106 1999 1246 1254
2. C. Fritsch, K. Lang, W. Neuse, T. Ruzicka, and P. Lehmann Skin Pharmacol. Appl. Skin Physiol. 11 1998 358 373
3. J.C. Kennedy, R.H. Pottier, and D.C. Pross J. Photochem. Photobiol. B 6 1990 143 148
4. J.C. Kennedy, S.L. Marcus, and R.H. Pottier J. Clin. Laser Med. Surg. 14 1996 289 304
5. Q. Peng, K. Berg, J. Moan, M. Kongshaug, and J.M. Nesland Photochem. Photobiol. 65 1997 235 251
6. J.C. Kennedy, and R.H. Pottier J. Photochem. Photobiol. B 14 1992 275 292
7. F.S. De Rosa, and M.V.L.B. Bentley Pharm. Res. 17 2000 1447 1455
8. K. Kalka, H. Merk, and H. Mukhtar J. Am. Acad. Dermatol. 42 2000 389 413
9. B.W. Henderson, and T.J. Dougherty Photochem. Photobiol. 55 1992 145 157
10. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng J. Natl. Cancer I. 90 1998 889 905
11. J. Webber, D. Kessel, and D. Fromm J. Surg. Res. 68 1997 31 37
12. R. Waidelich, W. Beyer, R. Knuchel, H. Stepp, R. Baumgartner, J. Schroder, A. Hofstetter, and M. Kreigmair Urology 61 2003 332 337
13. M. Novo, G. Huttmann, and H. Diddens J. Photochem. Photobiol. B 34 1996 143 148
14. R. Baumgartner, M. Kreigmair, and H. Stepp Opt. Methods Tumour Treat. Detect. SPIE 1881 1993 20 25
15. A. Bunke, O. Zerbe, H. Schmid, G. Burmeister, H.P. Merkle, and B. Gander J. Pharm. Sci. 89 2000 1335 1341
16. G.A. Shabir J. Chromatogr. A 987 2003 57 66
17. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use, ICH-Topic Q2B: Validation of Analytical Procedures: Methodology. Geneva, Switzerland, 1996.
18. British Standard BSEN 1616, Sterile Urethral Catheters for Single use, 1997.
19. H. Oishi, H. Nomiyama, K. Nomiyama, and K. Tomokuni J. Anal. Toxicol. 20 1996 106 110
20. B. Elfsson, I. Wallin, S. Eksborg, K. Rudaeus, A.M. Ros, and H. Ehrsson Eur. J. Pharm. Sci. 7 1998 87 91
21. O.B. Gadmar, J. Moan, E. Scheie, L.W. Ma, and Q. Peng J. Photochem. Photobiol. B 67 2002 187 193
22. A. Bunke, H. Schmid, G. Burmeister, H.P. Merkle, and B. Gander J. Chromatogr. A 883 2000 285 290
23. L. Bourre, S. Thibaut, A. Briffaud, Y. Lajat, and T. Patrice Pharmacol. Res. 45 2002 159 165
24. S. Lieb, R.M. Szeimies, and G. Lee Eur. J. Pharm. Biopharm. 53 2002 99 106
25. P.A. McCarron, R.F. Donnelly, A.D. Woolfson, and A. Zawislak Drug Deliv. Sys. Sci. 3 2003 59 64
26. M.J. O'Neil, A. Smith, P.E. Heckelman, The Merck Index Thirteenth Edition, Merck & Co. Inc., Whitehouse Station, NJ, USA.
27. J.T. Dalton, D. Zhou, A. Mukherjee, D. Young, E.A. Tolley, A.L. Golub, and M.C. Meyer Pharm. Res. 16 1999 288 295
28. A.W. De Blois, R.J.E. Grouls, E.W. Ackerman, and W.J.A. Wijdeven Laser Med. Sci. 17 2002 208 215
29. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use, ICH-Topic Q6A: Test Procedures and Acceptance Criteria for New Drug Products: Chemical Substances. Geneva, Switzerland, 2003.
30. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use, ICH-Topic Q6B: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. Geneva, Switzerland, 2003.
31. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use, ICH-Topic Q3B(R): Impurities in New Drug Products. Geneva, Switzerland, 2003.